Literature DB >> 3566455

Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls.

R T Rubin, R E Poland, I M Lesser, R A Winston, A L Blodgett.   

Abstract

To examine both predexamethasone and postdexamethasone cortisol measures in depression, we determined circadian serum cortisol patterns, cortisol responses to dexamethasone, and 24-hour urinary free cortisol excretion before and after dexamethasone administration in 40 patients with primary, definite endogenous depression diagnosed by Research Diagnostic Criteria and in 40 individually matched normal control subjects. Fifteen patients (38%) were dexamethasone nonsuppressors; they had significantly higher predexamethasone serum and urine cortisol measures than both their matched controls and the 25 suppressor patients. Both the predexamethasone and postdexamethasone cortisol measures were unimodally distributed across the patients and the controls. Circadian cortisol rhythms of similar magnitude occurred in both groups. The cortisol measures before and after dexamethasone administration were positively correlated to a similar degree in the patients and their controls, suggesting that predexamethasone hypothalamic-pituitary-adrenocortical hyperactivity and postdexamethasone cortisol nonsuppression are not independently determined in endogenous depression.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3566455     DOI: 10.1001/archpsyc.1987.01800160032006

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  42 in total

1.  Peri-sleep-onset cortisol levels in children and adolescents with affective disorders.

Authors:  Erika E Forbes; Douglas E Williamson; Neal D Ryan; Boris Birmaher; David A Axelson; Ronald E Dahl
Journal:  Biol Psychiatry       Date:  2005-08-22       Impact factor: 13.382

Review 2.  Mood-related central and peripheral clocks.

Authors:  Kyle D Ketchesin; Darius Becker-Krail; Colleen A McClung
Journal:  Eur J Neurosci       Date:  2018-11-29       Impact factor: 3.386

3.  Differential effects of chronic antidepressant treatment on swim stress- and fluoxetine-induced secretion of corticosterone and progesterone.

Authors:  G E Duncan; D J Knapp; S W Carson; G R Breese
Journal:  J Pharmacol Exp Ther       Date:  1998-05       Impact factor: 4.030

4.  Sex differences in cortisol response to corticotropin releasing hormone challenge over puberty: Pittsburgh Pediatric Neurobehavioral Studies.

Authors:  Laura R Stroud; George D Papandonatos; Douglas E Williamson; Ronald E Dahl
Journal:  Psychoneuroendocrinology       Date:  2011-04-13       Impact factor: 4.905

Review 5.  Disruption of fetal hormonal programming (prenatal stress) implicates shared risk for sex differences in depression and cardiovascular disease.

Authors:  J M Goldstein; R J Handa; S A Tobet
Journal:  Front Neuroendocrinol       Date:  2013-12-16       Impact factor: 8.606

6.  Reduced activity of hypothalamic corticotropin-releasing hormone neurons in transgenic mice with impaired glucocorticoid receptor function.

Authors:  I Dijkstra; F J Tilders; G Aguilera; A Kiss; C Rabadan-Diehl; N Barden; S Karanth; F Holsboer; J M Reul
Journal:  J Neurosci       Date:  1998-05-15       Impact factor: 6.167

Review 7.  Pharmacoendocrinology of major depression.

Authors:  R T Rubin
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

8.  Evolving refractory major depressive disorder diagnostic and treatment paradigms: toward closed-loop therapeutics.

Authors:  Matthew P Ward; Pedro P Irazoqui
Journal:  Front Neuroeng       Date:  2010-05-31

9.  Impact of sleep and its disturbances on hypothalamo-pituitary-adrenal axis activity.

Authors:  Marcella Balbo; Rachel Leproult; Eve Van Cauter
Journal:  Int J Endocrinol       Date:  2010-06-09       Impact factor: 3.257

Review 10.  Corticosteroid-serotonin interactions in depression: a review of the human evidence.

Authors:  Richard J Porter; Peter Gallagher; Stuart Watson; Allan H Young
Journal:  Psychopharmacology (Berl)       Date:  2004-03-09       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.